Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
NCT00044291Phase 3Completed
- Sponsor
- Intarcia Therapeutics
- Start
- Jun 2002
- Primary completion
- Jan 2006
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 4
01
Overview
A Phase 3 trial of atamestane in breast cancer, sponsored by Intarcia Therapeutics. Started Jun 2002; status: completed.
02
Drugs
atamestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00044291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044291.